Primary Site >> Biliary tract Cancer
Gene >> SLC2A1
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Assessment of Glut-1 expression in cholangiocarcinoma, benign biliary lesions and hepatocellular carcinoma. PMID: 12066193 Ref: Expression of the GLUT1 glucose transporter in gallbladder carcinomas. PMID: 12143238 |
Ref: Diagnostic utility of GLUT1 in the differential diagnosis of liver carcinomas. PMID: 15362741 |
Ref: Different glucose uptake and glycolytic mechanisms between hepatocellular carcinoma and intrahepatic mass-forming cholangiocarcinoma with increased (18)F-FDG uptake. PMID: 16204727 |
Ref: Expression of glucose transporters and hexokinase II in cholangiocellular carcinoma compared using [18F]-2-fluro-2-deoxy-D-glucose positron emission tomography. PMID: 18271924 |
Ref: Expression of cyclooxygenase-2, glucose transporter-1 and angiogenesis in gallbladder carcinomas and their impact on prognosis. PMID: 19606394 |
Ref: Expression of the GLUT1 glucose transporter and p53 in carcinomas of the pancreatobiliary tract. PMID: 19819644 Ref: Cyclooxygenase-2, p53 and glucose transporter-1 as predictors of malignancy in the development of gallbladder carcinomas. PMID: 20846124 |
Ref: Glucose transporter-1 (GLUT-1) immunoreactivity in benign, premalignant and malignant lesions of the gallbladder. PMID: 20512538 Ref: The prognostic relevance of tumor hypoxia markers in resected carcinoma of the gallbladder. PMID: 21109386 |
Ref: Expression of GLUT-1 and GLUT-3 in xanthogranulomatous cholecystitis induced a positive result on (1)(8)F-FDG PET: report of a case. PMID: 24229026 |
Ref: Different expression of glucose transporters in the progression of intrahepatic cholangiocarcinoma. PMID: 24824030 |
Ref: Analysis of the roles of glucose transporter 1 and hexokinase 2 in the metabolism of glucose by extrahepatic bile duct cancer cells. PMID: 25608150 Ref: Cholangiocarcinoma: Correlation between Molecular Profiling and Imaging Phenotypes. PMID: 26207380 Ref: Prognostic molecular markers in resected extrahepatic biliary tract cancers; a systematic review and meta-analysis of immunohistochemically detected biomarkers. PMID: 26223884 |
Ref: Inhibition of hypoxia inducible factor 1 and topoisomerase with acriflavine sensitizes perihilar cholangiocarcinomas to photodynamic therapy. PMID: 26657503 Ref: Metabolic characteristics distinguishing intrahepatic cholangiocarcinoma: a negative pilot study of (18)F-fluorocholine PET/CT clarified by transcriptomic analysis. PMID: 27069767 |
Ref: Preoperative metabolic tumor volume of intrahepatic cholangiocarcinoma measured by (18)F-FDG-PET is associated with the KRAS mutation status and prognosis. PMID: 29642912 |